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Rag GTPaseThe TOR pathway mediates nutrient-responsive regulation of cell growth and metabolism in animals. TOR
Complex 1 activity depends, amongst other things, on amino acid availability. MAP4K3 was recently
implicated in amino-acid signaling in cell culture. We report here the physiological characterization of
MAP4K3mutant ﬂies. Flies lacking MAP4K3 have reduced TORC1 activity detected by phosphorylation of S6K
and 4EBP. Furthermore MAP4K3 mutants display phenotypes characteristic of low TORC1 activity and low
nutrient availability, such as reduced growth rate, small body size, and low lipid reserves. The differences
between control and MAP4K3 mutant animals diminish when animals are reared in low-nutrient conditions,
suggesting that the ability of TOR to sense amino acids is most important when nutrients are abundant.
Lastly, we show physical interaction between MAP4K3 and the Rag GTPases raising the possibility they might
be acting in one signaling pathway.eman@dkfz.de (A.A. Teleman).
ll rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
The multiprotein complex TORC1, containing TOR kinase, is a
central regulator of cellular growth and metabolism in animals
(Bjornsti and Houghton, 2004; Guertin and Sabatini, 2007). It is
activated by a number of inputs relating to cellular energy andnutrient
status. These include insulin, glucose, cellular energy levels and amino
acid availability (Avruch et al., 2006; Hay and Sonenberg, 2004). In
response, TORC1 activates protein synthesis via a number of mechan-
isms including activation of the ribosomal S6 kinase (S6K), repression
of the translational inhibitor 4E-BP, and promotion of ribosome
biogenesis viamyc (Hay and Sonenberg, 2004; Telemanet al., 2008). In
particular since TORC1 is amaster regulator of protein biosynthesis, its
regulation by amino acids, the building blocks of proteins, likely
constitutes an important regulatory feedback mechanism. Further-
more, the importance of amino acid signaling to TOR is highlighted by
the observation that circulating amino acids are elevated in humans
with obesity, where they have been shown to activate TORC1 activity
and modulate glucose metabolism (Krebs, 2005). Despite this, our
understanding of the molecular mechanism by which amino acids
regulate TOR remains fragmentary.
Three protein complexes have recently been implicated in the
activation of TORC1 in response to amino acids. The human class III
PI3K (phosphoinositide 3-kinase) hVps34 is activated by amino acidsvia a calcium dependent mechanism (Gulati et al., 2008). This leads to
accumulation of phosphatidylinositol 3-phosphate (PI(3)P) in cells,
which is thought to cause the recruitment of proteins recognizing PI
(3)P to early endosomes, forming an intracellular signaling platform
that leads to TORC1 activation (Byﬁeld et al., 2005; Nobukuni et al.,
2005). This feature of the pathway may be speciﬁc for vertebrates, as
ﬂiesmutant for Vps34 have been reported to not have TORC1 signaling
defects (Juhasz et al., 2008). Recently, two groups discovered that Rag
GTPases mediate amino acid signaling to TORC1 (Kim et al., 2008;
Sancak et al., 2008). The emerging picture is that amino acids change
the GDP/GTP loading of the Rag GTPases, thereby stimulating the
binding of Rag heterodimeric complexes to TORC1. This in turn causes
TORC1 to change its intracellular localization, perhaps relocalizing it to
vesicles containing the activator Rheb. This mechanism appears to be
evolutionarily conserved from ﬂies to humans.
The third protein recently identiﬁed as a mediator of amino acid
signaling to TOR isMAP4K3 (Findlay et al., 2007). Findlay et al., (2007)
showed in HeLa cells that the kinase activity of MAP4K3 is activated in
the presence of amino acids. In turn, MAP4K3 is required for TOR to
phosphorylate its targets S6K and 4E-BP1 in response to amino acid
sufﬁciency. The cell-culture data also suggest this mechanism is
conserved from ﬂies to humans as knockdown of Drosophila MAP4K3
causes a reduction in TOR activity.
Although considerable progresshas beenmade, important questions
remain unanswered. The role of TORC1 activity in vivo has been well
studied in ﬂies and mice, but fundamental issues regarding the
regulation of TOR by amino acids have thus far only been explored in
vitro in cell culture. To assess the functional signiﬁcance of the ability of
TORC1 to sense amino acids in the organismal context we have made
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dMAP4K3 mutant ﬂies have reduced TOR activity, detected by
phosphorylation of TOR targets. dMAP4K3 mutants are viable but
display physiological aberrations emblematic of animals starved of
nutrients:MAP4K3mutantﬂies have retarded growth, reduced size, and
low lipid reserves. Both the biochemical results and the phenotypes
indicate thatMAP4K3modulates, but is not absolutely required, for TOR
activity in vivo. This is similar towhat is observedwith othermodulators
of the pathway, such as Melted. Unexpectedly, the function of MAP4K3
is most required when nutrient conditions are rich.
Materials and methods
Expression constructs and ﬂy lines
Flies containing the l(2)SH1261 P-element insertion were obtained
from the Bloomington Stock Center. The construct for expressing HA-
tagged MAP4K3 in S2 cells was built by subcloning cDNA GH26057
(BACPAC Resources Center) as a EcoRV–SalI fragment into pRmHa3b,
containing a copper-inducible promoter. An HA-tag was introduced
at the C-terminus of MAP4K3 into the NheI site, using oligos 5'-
CTAGCTACCCCTACGACGTCCCGGACTATGCCTAA-3' and 5'-CTAGTTAGG-
CATAGTCCGGGACGTCGTAGGGGTAG-3'. Similar constructs were built
for RagA and RagC by amplifying their coding sequences from
cDNA using oligos 5'GCGGCCGCAAGAAAAAGGTGTTACTGATGGG-3'
and 5'-CTCGAGCGGCAAATGGAGTTATGGAA-3' for RagA and 5'-GCGG-
CCGCAGCTACGATGATGATGACTATCC-3' and 5'-CTCGAGTTTTT-
TACGCTGCTCTGTGA-3' for RagC. A FLAG-tag was introduced into the
NotI site at the N-terminus using oligos 5'-GGCCATGGACTACAAGGAC-
GACGACGACAAG-3' and 5'-GGCCCTTGTCGTCGTCGTCCTTGTAGTCCAT-
3'. All ﬁnal constructs were veriﬁed by sequencing. Mutant versions of
MAP4K3, RagA and RagC were generated by standard point mutagen-
esis. MAP4K3 mRNA levels were tested by quantitative RT-PCR using
oligos 5'-AACGTGGACAGCATTGTTTG-3' and 5'-CTCTCCAAGGCC-
ACAACC-3'.
In vivo growth analyses and food conditions
Flies were grown under “growth controlled” conditions as
described previously (Teleman et al., 2005a). Flies were grown on a
rich food diet consisting of 3 L water, 36 g agar, 54 g dry yeast, 30 g
soya powder, 66 g sirup, 240 g malt extract, 240 g corn powder,
18.6 mL propionic acid and 7.2 g nipagin. For low-nutrient challenge,
20% food was prepared by mixing with PBS/0.6% agarose. Triglyceride
measurements and size measurements were performed as described
(Teleman et al., 2005a).
Immunoprecipitation and immunoblotting
Immunoprecipitations and immunoblotting were performed as
described previously (Teleman et al., 2005b). Anti-HA (Roche,
11867423001); anti-FLAG (Sigma, F1804) anti-pS6K(Thr398) (Cell
Signaling 9209 S); anti-pT37/46 4EPB1 (Cell Signaling 9459 S); anti-
engrailed (Developmental Studies Hybridoma Bank).
Results
Drosophila MAP4K3 mutants are viable
In order to study the in vivo function of amino acid sensing by
MAP4K3, we screened a panel of publicly available Drosophila lines
harboring P-element insertions in or near the dMAP4K3 (CG7097)
locus for loss of dMAP4K3 expression. The l(2)SH1261 P-element is
inserted in the second intron of dMAP4K3 (Fig. 1A). By quantitative
RT-PCR, we found that ﬂies homozygous for the l(2)SH1261 insertion
have expression levels of dMAP4K3 that are only 1% that of controlﬂies (Fig. 1B). We back-crossed female ﬂies harboring the l(2)SH1261
insertion to w1118 ﬂies for four generations in order to obtain two ﬂy
stocks with similar genetic backgrounds, differing by presence or
absence of the l(2)SH1261 insertion. The resulting stocks were then
used for all experiments described here, and we will refer to such ﬂies
homozygous for the l(2)SH1261 insertion as MAP4K3 mutant ﬂies,
and the w1118 stock as control.
MAP4K3 mutant ﬂies were able to reach adulthood, looked
normally patterned, and were fertile. Nonetheless, they were not
completely normal as they had reduced viability compared to control
ﬂies. Only 77% of MAP4K3 mutant ﬁrst-instar larvae reached
adulthood, compared to 91% of controls (t-test 0.001, Fig. 1C). Within
the ﬁrst 2 days of life, 18% ofMAP4K3mutants died, compared to 7% of
controls (t-test b0.001, Fig. 1C), suggesting MAP4K3 mutants are
generally weaker than controls.
MAP4K3 mutants have reduced TOR activity levels in vivo
Knockdown of MAP4K3 in Drosophila S2 cells has been reported to
reduce TOR activity (Findlay et al., 2007). We asked whether MAP4K3
mutant animals also have lower TOR activity compared to controls.
We extracted protein from control and MAP4K3 mutant adult males
and assayed TOR activity by detecting phosphorylation of two TOR
targets, S6K and 4EBP (Fig. 2). MAP4K3 mutants compared to control
animals had signiﬁcantly reduced S6K and 4EBP phosphorylation
levels (Fig. 2). As an additional control, we generated animals bearing
a precise excision of the l(2)SH1261 P-element insertion, which
should revert the lesion causing theMAP4K3mutation, and hence the
loss-of-function phenotype. In these animals, phosphorylation of S6K
and 4EBP were returned to normal levels (Fig. 2).
MAP4K3 mutants have retarded growth and reduced size
We asked whether MAP4K3 mutant ﬂies display phenotypes
canonical of reduced TOR activity, such as reduced organismal growth
rate and smallerﬁnal body size inpart due to smaller cells.Whenequally
staged MAP4K3 mutant and control ﬁrst-instar larvae were seeded at
deﬁned density in vials containing normal laboratory food,which is rich
in amino acids and other nutrients (hereafter referred to as “controlled
growth conditions”), MAP4K3 mutants were delayed in pupation
relative to controls by almost 2 days (Fig. 3A). We could not detect
any defects in ecdysone signaling in MAP4K3 mutants, assayed by
quantitative RT-PCR of transcriptional targets of the pathways (Supple-
mentary Fig. 1). Instead, MAP4K3 mutants displayed a slower growth
rate during larval stages. MAP4K3 mutant larvae were signiﬁcantly
smaller than equally aged control larvae, as was evident by visual
inspection 4 and 5 days after egg laying (Fig. 3B) and when quantiﬁed
(Fig. 3C). Growth curves obtained byweighing larvae at successive days
of development showed thatMAP4K3mutants accumulatedmass more
slowly than controls (Fig. 3D).MAP4K3mutants also displayed a larger
inter-individual variation in growth rate compared to controls, as can be
seen by the larger standard deviation in the size (Fig. 3C) and the
shallower pupation curve of theMAP4K3mutant population compared
to controls (Fig. 3A).MAP4K3mutant adult ﬂies were also signiﬁcantly
reduced in size, as could be quantiﬁed bymeasuring wing area. Mutant
wings were roughly 20% smaller than wings from control ﬂies
(t-test=1×10−7, Fig. 3E). The difference in size between mutant and
control adults was smaller than the difference between co-aged larvae
due to the 2-day extended larval growth period of themutants allowing
them to grow to near normal size before pupation. In order to quantify
cell size in MAP4K3 mutant adults, we measured hair number per unit
area in MAP4K3 mutant and control wings (Fig. 3F). MAP4K3 mutants
had a signiﬁcantly reduced cell size compared to controls
(t-test=2×10−5, Fig. 3F). Since only strong growth defects can be
readily observed using mitotic clones, we could not detect striking
Fig. 1.MAP4K3 mutant ﬂies are viable. (A) Overview of the dMAP4K3 (CG7097) genomic locus, showing insertion point of the l(2)SH1261 P-element relative to the two dMAP4K3
splice isoforms. l(2)SH1261 is inserted in the second intron of the gene. (B) Quantitative RT-PCR on dMAP4K3 mRNA normalized to rp49. Flies homozygous for the l(2)SH1261
insertion have 1% the level of MAP4K3 expression as compared to w1118 ﬂies (“control”). Error bars indicate standard deviation. (C) Survival curve for control (dark bars) and
MAP4K3 mutant ﬂies (light bars). The majority of MAP4K3 mutant ﬂies survive to adulthood (“adults”) although viability is slightly but signiﬁcantly reduced compared to control
ﬂies (t-test=0.001). A signiﬁcant number of MAP4K3 mutant adults die the ﬁrst 2 days of life (circa 20%), signiﬁcantly more than controls (t-test b0.001). Error bars indicate
standard deviation and * indicates signiﬁcance.
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Fig. 2).MAP4K3 mutants are lean
Signaling through the insulin and TOR pathways has a signiﬁcant
impact on ﬂy metabolism (Baker and Thummel, 2007; Teleman et al.,
2005b). We asked whether MAP4K3 mutant animals have altered
metabolic characteristics compared to controls. Triglyceride levels are
one important metabolic parameter in Drosophila, as ﬂies store most ofFig. 2.MAP4K3 mutant ﬂies have reduced TOR activity. Protein extracts from 5-day-old
adult males of control, MAP4K3 mutant or l(2)SH1261 excision ﬂies, probed for
phospho- and total S6K and 4EBP protein as indicated.their energy in the form of triglycerides in their adipose tissue (Van der
Horst, 2003). We reared mutant and control animals under controlled
growth conditions, and measured total body triglycerides, normalized
to total body protein to control for animal size.MAP4K3mutant animals
had roughly 40% less fat than control animals (t-testb0.01, Fig. 4A). This
phenotypewas reversed in animals bearing a precise excision of the l(2)
SH1261 P-element insertion (t-testb0.01, Fig. 4A). As a further control,
ﬂies trans-heterozygous for the l(2)SH1261 P-element insertion over a
deﬁciency uncovering the MAP4K3 locus were also lean (Fig. 4B, t-test
b0.01). The leanness of MAP4K3 mutants could be reversed by
expressing MAP4K3 via a UAS transgene together with the low-level
ubiquitous driver daughterless-GAL4 (Fig. 4C, t-test b 0.01).
The combination of growth and metabolic phenotypes displayed
by MAP4K3 mutants–reduced growth rate and low lipid levels–
suggest that the mutant animals are reacting physiologically as if they
were nutritionally starved, even though nutrients are available.
We postulated that the starvation-like phenotypes of MAP4K3
mutant ﬂies might be exacerbated by rearing animals in a condition
where nutrient supply is limiting, rather than in high abundance as
under standard laboratory conditions. To this end, we seeded ﬁrst-
instar larvae on food that had been diluted 1:5 with PBS/agarose,
reducing the concentration of all nutrients. Under these conditions,
both mutant and control animals took longer to pupate than under
normal food conditions (Fig. 3A and A'). To our surprise, however,
MAP4K3 mutants were no longer disadvantaged in terms of growth
rate, and pupated at the same time as control ﬂies (Fig. 3A'). This
ﬁnding is consistent with cell culture data showing that MAP4K3 is
required for full activation of TOR in the presence of amino acids, but
is less important for TOR activation in the absence of amino acids
Fig. 3.MAP4K3mutantﬂies display TOR-like growthphenotypes. (A,A’) Pupationcurves for control (darkgraphs) andMAP4K3mutantﬂies (light graphs). Flieswere grownon(A) normal
laboratory food or (A') normal laboratory food diluted 1:5 with PBS/agarose to generate a condition of limiting food supply. Error bars indicate standard deviation. (B) MAP4K3 mutant
larvae are smaller thanequally aged control larvae, both 4 and5 days after egg laying (4dAEL and5dAEL respectively). (C)Quantiﬁcation of larval size of equally aged,male animals grown
under controlled conditions (50 animals per vial). Size was quantiﬁed by measuring the area of individual larvae on pictures. Control, MAP4K3 mutant and l(2)SH1261 precise excision
animals (“precise excision”) as indicated. Error bars indicate standard deviation. ** and * indicate statistically signiﬁcant differences (t-test=0.002 and 0.01 respectively). (D) Growth
curves of control and MAP4K3 mutant larvae seeded on normal laboratory food at a density of 50 larvae per vial in triplicate. Larval weights were measured on indicated days after egg
laying. Error bars indicate standarddeviation. (E) Relativewing size of control andMAP4K3mutantﬂies. Error bars indicate standarddeviation. *MAP4K3mutantwingswere signiﬁcantly
smaller (t-test=1×10−7). (F)Wing cell size is reduced inMAP4K3mutant animals compared to controls. Cell size in thewingwasmeasured by counting hairs for an area of deﬁned size,
posterior to vein 5. Error bars indicate standard deviation.Mutant animals have signiﬁcantly smaller cells than control animals (t-test=2×10−5 indicated by *). In all cases (A–F), animals
were grown under controlled conditions, seeded as ﬁrst instars at a density of 50 animals per vial.
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between control and MAP4K3 mutant ﬂies is speciﬁcally due to the
sensing of amino acids, we generated food in which the two amino-
acid rich ingredients, yeast extract and soy meal, were reduced to 20%
their normal concentration whereas all other ingredients, including
the carbohydrate-rich malt extract, were left normal. Whereas
MAP4K3mutant animals displayed a growth delay relative to controls
on normal laboratory food (Fig. 5A), both control andMAP4K3mutant
animals grew equally slowly on low-amino acid food, so that the
difference between the two genotypes was no longer statistically
signiﬁcant (Fig. 5B). We also assessed activation of TOR in control andMAP4K3mutant larvae grown on normal and low-amino acid food, by
quantifying phosphorylation of S6K (Fig. 5C). On normal food,
MAP4K3 mutant animals had reduced levels of phospho-S6K com-
pared to control animals (Fig. 5C, lanes 1 and 2). Whereas
phosphorylation of S6K dropped in wildtype animals growing on
low-amino acid food compared to normal food (Fig. 5C, lanes 1 and 3),
this drop was not visible in MAP4K3 mutant animals (Fig. 5C, lanes 2
and 4). Together, these data suggest that MAP4K3 is required in vivo
to activate TOR and spur growth when amino acid conditions are rich,
whereas its activity is not as necessary when amino acid levels are
limiting.
Fig. 4.MAP4K3mutant ﬂies are lean. (A) Relative triglyceride levels, normalized to total
body protein, for control ﬂies, MAP4K3- mutant ﬂies homozygous for the l(2)SH1261
insertion (“map4k3-”) and ﬂies in which the P-element was precisely excised (“precise
excision”). (B) Relative triglyceride levels, normalized to total body protein, for control
ﬂies, MAP4K3- mutant ﬂies homozygous for the l(2)SH1261 insertion (“map4k3-”),
and ﬂies trans-heterozygous for the l(2)SH1261 insertion over the deﬁciency Df(2R)
Exel6069 uncovering the MAP4K3 locus (map4k3-/Df). (C) Relative triglyceride levels,
normalized to total body protein, for map4k3 mutant ﬂies carrying either the
daughterless-GAL4 driver (“map4k3-; da-G4”), or a UAS-MAP4K3 transgene
(“map4k3-; UAS-MAP4K3”) or both, resulting in ubiquitous low-level expression of
MAP4K3 in the map4k3 mutant background (“map4k3-; daNMAP4K3”). In all cases,
error bars indicate standard deviation and * indicates statistical signiﬁcance (t-test
b0.01).
Fig. 5. Effects of amino acids on MAP4K3mutant phenotypes. (A, B) Pupation curves for
control (dark graphs) and map4k3 mutant ﬂies (light graphs). Flies were grown in
parallel on (A) normal laboratory food or (B) food containing only 1/5th the normal
amount of yeast extract and soy meal, the two principle amino-acid containing
components. Error bars indicate standard deviation. (C) Protein extracts from control or
MAP4K3 mutant pre-wandering third-instar female larvae, probed for phospho- and
total S6K, and ERK as a loading control.
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While working with MAP4K3, we noticed MAP4K3 protein
contains a CNH domain at its C-terminal end. This domain is present
in other kinases such as Citron kinase andMyotonic dystrophy kinase-
related Cdc42-binding kinase (MRCKa), which interact with small
GTPases such as Rho and Cdc42 (Madaule et al., 1995; Zhao and
Manser, 2005). Therefore, we postulated that MAP4K3 might interact
with a small GTPase in the TOR signaling pathway. To this end, we
tested whether MAP4K3 can bind Rheb, an activator of TOR. We
expressed HA-tagged MAP4K3 and myc-tagged Rheb in S2 cells, and
performed immunoprecipitations in both directions (anti-HA and
anti-myc), but were not able to detect any binding between MAP4K3
and Rheb (data not shown). Recently, a new set of GTPases have been
reported to regulate TOR—the Rag GTPases (Kim et al., 2008; Sancak et
al., 2008). Unlike Rheb, the Rag GTPases are important for TOR to beresponsive to amino acids. To test whether MAP4K3 can bind Rag
GTPases, we expressed HA-MAP4K3 together with FLAG-dRagA and
FLAG-dRagC in S2 cells and immunoprecipitated RagA and RagC with
anti-FLAG antibody (Fig. 6A). HA-MAP4K3 could be strongly detected
in the FLAG immunoprecipitate (Fig. 6A, lane 3). As a control,
HA-MAP4K3 could not be detected in the immunoprecipitate from
lysates of cells not co-transfected with FLAG-RagA and FLAG-RagC
(Fig. 6A lane 1) showing that immunoprecipitation of MAP4K3
required presence of the Rag proteins. As a further control for
speciﬁcity, an unrelated HA-tagged protein (HA-Medea) was not
co-immunoprecipitated despite being present in the lysate at equal
levels as HA-MAP4K3 (Fig. 6A).
We then tested whether the interaction between MAP4K3 and the
RagA/C complex is dependent on the presence of amino acids or the
state of activation of TORC1. Inactivation of TORC1 with rapamycin had
no detectable effect on binding between MAP4K3 and the RagA/C
complex (Fig. 6B, lane 3), whereas amino acid removal caused a slight
but reproducible reduction in binding (Fig. 6B, lane 2). As a control for
effectiveness of the treatments, both rapamycin treatment and amino
acid removal caused complete dephosphorylation of the TOR substrate
S6K (Fig. 6B).
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Rag proteins and of MAP4K3 changes: Rag proteins change their GDP/
GTP loading (Kim et al., 2008; Sancak et al., 2008) whereas MAP4K3becomes dephosphorylated (Yan et al., 2010). To study in more detail
whether these events affect binding between MAP4K3 and the RagA/C
complex, we ﬁrst asked whether MAP4K3 binds preferentially to RagA
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FLAG-RagA or FLAG-RagC, or both combined. Notably, the binding to
RagCwas signiﬁcantly stronger than thebinding to RagA (Fig. 6C, lanes 1
and 2) suggesting that binding of MAP4K3 to the RagA/C complex is
mediated via binding to RagC. We then asked whether the activation
state of MAP4K3 or RagC affects binding of MAP4K3 to the RagA/C
complex. To this end, we generated a panel of mutations in either
MAP4K3 or RagC. Lamb and colleagues have reported that the
phosphorylation state of Ser170 of hMAP4K3 (Ser180 in Drosophila)
is dependent on the presence of amino acids (personal communication,
in press). Therefore, we generated dMAP4K3 variants in which Ser180
was mutated to either non-phosphorylatable alanine, or to glutamic
acid mimicking the phosphorylated state. Neither mutation, however,
affected binding of MAP4K3 to the RagA/C complex (Fig. 6D, lanes 2, 3
and 7). We also generated RagC variants that were either locked in the
GDP or GTP state, or had a phospho-mimicking mutation on Ser388
(S388E), as RagC is reported to be phosphorylated at this site in vivo
(http://www.phosphopep.org). Although mutation of Ser388 did not
alter binding between MAP4K3 and the RagA/C complex, locking RagC
into the GDP state strongly increased binding toMAP4K3 (Fig. 6D, lanes
4–7). Since amino acid availability regulates the GDP/GTP load of Rag
proteins (Kim et al., 2008; Sancak et al., 2008), we askedwhether amino
acids regulateMAP4K3/Ragbindingviamodulationof theRagGDP/GTP
load. Whereas removal of amino acids caused a slight reduction in
binding ofMAP4K3 to theRagA/RagC(WT) complex (Fig. 6E, lanes 1–2),
aminoacid removal no longerhad aneffectwhenRagCwas locked in the
GDP state (Fig. 6E, lanes 3–4). This suggests that amino acids regulate
MAP4K3/Rag binding by modulating the GDP/GTP load of the Rag
proteins.
These biochemical data suggest that MAP4K3 and the Rag GTPases
might work together in a signaling pathway mediating amino acid
signaling to TORC1. They do not, however, shed light on which
component is upstream of the other. To this end, we tested in vivo
genetic epistasis between MAP4K3 and RagA. Overexpression of
constitutively active RagA (Q61L) in Drosophila leads to tissue
overgrowth, as would be expected from activation of TORC1 (Kim et
al., 2008). Expression of RagA(Q61L) in the posterior compartment of
the wing with engrailed-GAL4 caused an increase in the size of this
compartment relative to the anterior (Fig. 6F, columns 1–4). When
RagA(Q61L) was expressed in the posterior compartment in a
map4k3-mutant background, it was still able to induce tissue
overgrowth (Fig. 6F, column 5), indicating that MAP4K3 is not
downstream of RagA.
Discussion
MAP4K3 mutant ﬂies display phenotypes typical of reduced TORC1
activity and reduced nutrient availability
Recent reports have shown that not all components identiﬁed in
cell culture as regulators of TORC1 activity also affect TORC1 in vivo in
an animal model (Juhasz et al., 2008). The purpose of our study was
two-fold: (1) to analyze whether MAP4K3 regulates TORC1 activity inFig. 6. dMAP4K3 interacts physically with dRagA and dRagC. (A) dMAP4K3 co-immunopr
expressing HA-dMAP4K3, HA-Medea, FLAG-dRagA, and FLAG-dRagC as indicated. Cell lysate
FLAG-tags. HA-MAP4K3 but not HA-Medea co-immunoprecipitates with FLAG-Rags (lane 3)
marks the heavy chain of the anti-FLAG antibody, which runs slightly above dRagC. “NS”mar
of rapamycin and amino-acid withdrawal on binding between MAP4K3 and RagA/C. Cells
treated with Schneider's medium lacking amino acids for 1 h prior to lysis. (C) dMAP4K3 bind
be detected more strongly in the FLAG immunoprecipitate when FLAG-RagC was expressed
between MAP4K3 and the RagA/C complex. MAP4K3 binds best to RagA/C complex when Ra
MAP4K3 containing a S180A (“A”) or S180E (“E”) mutation, as well as wildtype RagC (“WT”)
“GDP”) or RagC locked in the GTP conformation (Q99L, “GTP”). (E) Binding of MAP4K3 to R
state. Cells expressing wildtype MAP4K3 together with RagA and either RagC(WT) or cons
induce tissue growth also in the absence of MAP4K3. Wing posterior compartment area nor
engrailed-GAL4 ﬂies (enG4), as well as ﬂies expressing constitutively active RagA(Q61L
background (map4k3-; enG4NNUAS-RagA*). Error bars indicate standard deviation. *t-testbvivo in the ﬂy, and (2) to study the physiological consequences for the
organism when the ability of TORC1 to sense amino acids is impaired.
We present biochemical evidence that TORC1 activity is reduced in
MAP4K3 mutant animals, consistent with published cell-culture data
showing that MAP4K3 is required for full TORC1 activation (Findlay et
al., 2007). Furthermore, MAP4K3 mutants have defects typical of
reduced TORC1 activity. They are delayed in their development due to
a reduced rate of growth. They eventually pupate leading to adults of
reduced size and their tissues are comprised of cells that are smaller
than normal. Furthermore, MAP4K3 mutants have signiﬁcantly
reduced triglyceride stores compared to controls. These physiological
effects are similar to the phenotypes observed with mutants for other
regulators of TOR, such as Melted. Melted mutant ﬂies are also 10%
smaller than controls and are signiﬁcantly leaner (Teleman et al.,
2005b).
As a whole, the MAP4K3- mutant phenotypes emulate the
physiological effects observed when ﬂies are grown on conditions of
limiting food. When wildtype larvae are put on a low-nutrient diet,
they are delayed in pupation and yield animals of small size that are
lean (KH unpublished). Thus loss of MAP4K3 activity phenocopies a
reduced nutrient environment, consistent with MAP4K3 playing a
role in the ability of animals to sense their nutrient conditions. This
suggests the ability of TORC1 to sense amino acids is most important
when nutrient conditions are rich, allowing animals to accelerate their
growth accordingly. In contrast, on a low-nutrient diet, control and
MAP4K3 mutant ﬂies grow equally slowly (Figs. 3A', 5B) consistent
with TOR activity being low in both groups. This parallels nicely the
results reported in cell culture by (Findlay et al., 2007): In the absence
of amino acids, both control and MAP4K3 knockdown cells have low
TOR activity whereas in the presence of amino acids, TOR is activated
strongly in control cells but only weakly in MAP4K3 knockdown cells.
Unexpectedly, we found that MAP4K3 mutant animals are viable,
although they have an elevated mortality rate compared to controls.
This suggests that the amino acid sensingpathwaymight onlymodulate
TORC1 activity. If TORC1 activity were completely blunted in MAP4K3
mutants, the animals would be dead, as is the case for TOR or Rheb
mutants. Consistent with this, we observe residual TORC1 activity in
MAP4K3mutants, as detected by phosphorylation of the TORC1 targets
S6K and 4EBP. This also parallels results from cell culture. The results
presented in Findlay et al., 2007 are obtainedwith cells starved of serum
and consequently of insulin signaling. In the presence of insulin
signaling, which resembles the physiological situation more closely,
MAP4K3 mutant cells still retain residual TOR activity (unpublished),
similar to what we observe in vivo here. Consistent with these ﬁndings,
we observed that the Rheb expression is able to drive tissue growth also
in the absence of MAP4K3 (Supplementary Fig. 3).
MAP4K3 binds Rag GTPases
BothMAP4K3 and the Rag GTPases have recently been shown to be
required for amino acids to stimulate TORC1 activity. While studying
dMAP4K3, we noticed that dMAP4K3 binds physically to the Rag
GTPases, suggesting theymight act together as components of a singleecipitates with the dRagA/dRagC complex. S2 cells were transfected with constructs
s and FLAG-tag immunoprecipitates were analyzed by immunoblotting against HA- and
. HA-MAP4K3 does not precipitate in the absence of the FLAG-Rags (lane 1). “IgG” label
ks a non-speciﬁc band recognized by the anti-FLAG antibody in S2 cell lysates. (B) Effect
and lysates were treated as in (A) except cells were treated with 20 nM rapamycin or
s dRagCmore strongly than dRagA. Cells and lysates were treated as in (A). MAP4K3 can
compared to FLAG-RagA. (D) Effect of various MAP4K3 and RagC mutations on binding
gC is locked in the GDP conformation. Constructs used are wildtype MAP4K3 (“WT”) or
, RagC containing a S388E mutation (“E”), RagC locked in the GDP conformation (S54N,
agA/C is no longer sensitive to amino acid availability when RagC is locked in the GDP
titutively active RagC(Q61L) were treated as in (B). (F) Constitutively active RagA can
malized to anterior compartment area plotted for control w1118, map4k3 mutant, and
) either in the wildtype background (enG4NNUAS-RagA*) or in the map4k3 mutant
10–11 relative to w1118.
157B. Bryk et al. / Developmental Biology 344 (2010) 150–157signaling pathway. This interaction is likely speciﬁc for several
reasons: (1) we could not detect binding of MAP4K3 to another
GTPase, Rheb, (2) binding of MAP4K3 to the RagA/C complex was
signiﬁcantly stronger than binding of an unrelated HA-tagged protein,
HA-medea (3) MAP4K3 bound FLAG-RagC signiﬁcantly stronger than
FLAG-RagA showing that MAP4K3 distinguishes between two Rag
proteins and (4) binding of MAP4K3 to RagC depended on its GDP/
GTP state.
Further studies will be required to test whether this interaction is
important for TORC1 to sense amino acids. Our data suggest that
MAP4K3 might be functioning upstream of the Rag GTPases, and not
downstream since activated RagA does not require MAP4K3 to
promote tissue growth in vivo (Fig. 6F). This raises the possibility
that the Rag GTPases may be substrates for MAP4K3 phosphorylation.
Indeed, RagC is phosphorylated in vivo in Kc167 cells on Ser388
(http://www.phosphopep.org). If MAP4K3 were to phosphorylate
RagC, this would provide a mechanism for regulation of the Rag
GTPases, which to date is mysterious. Work in the near future should
shed further light on this issue.
In summary, we have characterized the physiological function of
MAP4K3 in Drosophila, and shown that it modulates TORC1 activity,
tissue growth and lipid metabolism in the animal. Physical interaction
data hints at a possible link betweenMAP4K3 and the Rag GTPases. We
show that the organismal function of amino acid sensing by TORC1 is
mainly required to spur growth when nutrient conditions are rich.
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